Purification of macrophage deactivating factor - PubMed (original) (raw)
Purification of macrophage deactivating factor
S Srimal et al. J Exp Med. 1990.
Abstract
Macrophage deactivation factor (MDF) in P815 tumor cell-conditioned medium was assayed by its suppression of the ability of activated mouse peritoneal macrophages to release hydrogen peroxide. MDF displayed properties of a soluble protein(s) associated with both low (8-25,000) and high (greater than 450,000) Mr fractions. MDF was purified 6,140-fold by a seven-step procedure: extraction with acid-ethanol; precipitation with ether; and fractionation on gel filtration, anion-exchange, diphenyl reversed-phase and C4 reversed-phase HPLC columns, the last column twice. The final preparation contained two species: (a) a approximately 13,000 Mr band on reducing or nonreducing SDS-PAGE and on autoradiograms after radioiodination with chloramine T, and (b) a 66,000 Mr species ranging from approximately 5% to approximately 50% of the protein detectable by silver strain. The 66,000 Mr species was identified as albumin from its NH2-terminal amino acid sequence. However, no amino acid sequence could be obtained for the approximately 13,000 Mr species, either in fluid phase or after electroelution of the corresponding SDS-PAGE band. Thus, approximately 13,000 Mr MDF associates tightly with albumin through a variety of separation techniques, and may have a blocked NH2 terminus. Purified MDF afforded 50% inhibition of activated macrophage H2O2 releasing capacity at a concentration of 1-10 nM. Separation of MDF from most higher Mr moieties was associated with disproportionately small increases in specific activity, suggesting MDF might be partially inactivated by purification. As purified, MDF was approximately 1,000-fold less potent at deactivating macrophages than TGF-beta. Antibodies that neutralized the macrophage-deactivating effect of TGF-beta did not inhibit deactivation by MDF.
Similar articles
- Towards large-scale purification of natural CSF-1 from human placenta tissue extracts.
Martin-Thouvenin V, Uhlrich S, Tayot JL, Lanotte M. Martin-Thouvenin V, et al. Biotechnol Appl Biochem. 1990 Apr;12(2):176-87. Biotechnol Appl Biochem. 1990. PMID: 2184839 - Inhibition of macrophage activity by mitogen-induced goldfish leukocyte deactivating factor.
Stafford J, Neumann NF, Belosevic M. Stafford J, et al. Dev Comp Immunol. 1999 Oct-Dec;23(7-8):585-96. doi: 10.1016/s0145-305x(99)00044-0. Dev Comp Immunol. 1999. PMID: 10579387 - Macrophage deactivation. Altered kinetic properties of superoxide-producing enzyme after exposure to tumor cell-conditioned medium.
Tsunawaki S, Nathan CF. Tsunawaki S, et al. J Exp Med. 1986 Oct 1;164(4):1319-31. doi: 10.1084/jem.164.4.1319. J Exp Med. 1986. PMID: 3020151 Free PMC article.
Cited by
- A journey in science: promise, purpose, privilege.
Nathan C. Nathan C. Mol Med. 2013 Oct 3;19(1):305-13. doi: 10.2119/molmed.2013.00063. Mol Med. 2013. PMID: 24089245 Free PMC article. - Suppression of the reactive oxygen intermediates production of human macrophages by colorectal adenocarcinoma cell lines.
Siegert A, Denkert C, Leclere A, Hauptmann S. Siegert A, et al. Immunology. 1999 Dec;98(4):551-6. doi: 10.1046/j.1365-2567.1999.00915.x. Immunology. 1999. PMID: 10594687 Free PMC article. - Macrophage deactivation by interleukin 10.
Bogdan C, Vodovotz Y, Nathan C. Bogdan C, et al. J Exp Med. 1991 Dec 1;174(6):1549-55. doi: 10.1084/jem.174.6.1549. J Exp Med. 1991. PMID: 1744584 Free PMC article. - Transforming growth factor beta 2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor alpha-independent early phase of experimental pneumococcal meningitis.
Pfister HW, Frei K, Ottnad B, Koedel U, Tomasz A, Fontana A. Pfister HW, et al. J Exp Med. 1992 Jul 1;176(1):265-8. doi: 10.1084/jem.176.1.265. J Exp Med. 1992. PMID: 1613460 Free PMC article.
References
- Aust J Exp Biol Med Sci. 1982 Oct;60 (Pt 5):493-502 - PubMed
- J Exp Med. 1982 Oct 1;156(4):945-61 - PubMed
- J Biol Chem. 1983 Aug 25;258(16):9631-5 - PubMed
- Biochim Biophys Acta. 1983 Nov 8;760(3):421-3 - PubMed
- J Immunol. 1984 Jul;133(1):448-53 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous